You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)

The agreement aims to improve patient access to coagulation disorders treatments in Europe

read more 

EVENTS

Kedrion Biopharma initiatives for World Hemophilia Day 2017

The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over

read more 

PLASMA & BIOTHERAPIES

Article by Prof. Farrugia and Daniela Scaramuccia published on “Biologicals”

International medical journal hosts review of contract plasma fractionation dynamics

read more 
For more information please contact: pressoffice@kedrion.com